dRx Capital

Peptone Ltd is a London-based company founded in 2016 that specializes in artificial intelligence solutions aimed at solving protein developability challenges within the biotechnology, biopharmaceutical, and life sciences sectors. The company offers a range of services, including antibody design and optimization, an extensive protein database, automated thermos-stability engineering, and the deployment of hybrid AI solutions. Its proprietary platform, CassandraAI, focuses on silico protein engineering, allowing for the efficient handling of complex tasks related to anomaly detection and failure risk assessment in protein development. By streamlining these processes, Peptone enables users to identify optimal pathways for therapeutic discovery, facilitating the generation of lab-quality molecules more swiftly and cost-effectively than traditional methods in the pharmaceutical industry.

Koneksa Health Inc. is a healthcare data analytics company that specializes in designing and developing software solutions for pharmaceutical and biotech firms. The company’s flagship product, Koneksa Compare, facilitates the collection, monitoring, and analysis of patient-generated data to support clinical studies and regulatory claims. By integrating emerging technologies such as bio-sensors, activity trackers, and mobile-based questionnaires, Koneksa enhances the accuracy and breadth of data that researchers can analyze, thereby minimizing subjective biases in clinical endpoints. Additionally, the platform provides a dashboard that offers electronic clinical outcome assessments and reminders for study participants. Established in 2013 and headquartered in New York, Koneksa also maintains a presence in London, United Kingdom, and is recognized for its contributions to improving the efficiency of drug development through innovative data analysis.

H1 provides a global healthcare platform that connects life sciences companies, hospitals, academic medical centers, and health systems with providers, enables access to clinical research, helps locate industry experts, and supports benchmarking of organizations. As a trusted source of information on healthcare professionals and institutions, the platform combines real-time data and clinical findings to illuminate the broader healthcare ecosystem. The company, founded in 2017 and based in New York, also offers a healthcare data analytics capability that delivers real-time, end-to-end insights across the data landscape to support therapeutic development—from fundraising and product development to product launch.

Flywheel.io is a cloud-based data management platform tailored for biomedical research and collaboration. Founded in 2012 and headquartered in Minneapolis, Minnesota, the company provides a suite of tools designed to enhance the workflow of scientists and researchers. Its platform supports medical imaging, scientific computation, and content management, enabling users to capture, manage, and analyze research data efficiently. By utilizing cloud scalability and automation, Flywheel facilitates collaborative research, machine learning applications, and multicenter studies, which help organizations streamline their research processes. The platform, featuring a modern web interface and extensible compute engine, aims to eliminate bottlenecks in innovation, allowing researchers to focus on scientific discovery rather than IT challenges.

Dopavision GmbH, founded in 2017 and based in Berlin, Germany, specializes in developing a digital therapeutic aimed at treating myopia, commonly known as shortsightedness. This condition impacts approximately one in three individuals globally and has seen a significant rise in prevalence over the past two decades. The company's innovative approach involves delivering light stimulation to specific photosensitive cells in the retina, which helps modulate dopamine levels—a neurotransmitter crucial for regulating eye growth. By focusing on children and adolescents, Dopavision aims to create a clinically validated therapy that can effectively slow myopia progression. The therapeutic solution is designed to be seamlessly integrated with smartphone technology, allowing for an accessible and user-friendly treatment option.

NuvoAir is a healthcare technology company that offers a value-based specialty care platform and remote monitoring tools for chronic heart and lung conditions. Founded in 2015 and based in Stockholm, Sweden, it develops home respiratory monitoring and analytics delivered by a multidisciplinary team of pulmonologists and cardiologists. The platform enables proactive virtual care and partners with health plans and risk-bearing entities under flexible, value-based payment arrangements to improve patient outcomes and reduce healthcare costs by enabling early detection of deterioration and personalized management.

Flywheel.io is a cloud-based data management platform tailored for biomedical research and collaboration. Founded in 2012 and headquartered in Minneapolis, Minnesota, the company provides a suite of tools designed to enhance the workflow of scientists and researchers. Its platform supports medical imaging, scientific computation, and content management, enabling users to capture, manage, and analyze research data efficiently. By utilizing cloud scalability and automation, Flywheel facilitates collaborative research, machine learning applications, and multicenter studies, which help organizations streamline their research processes. The platform, featuring a modern web interface and extensible compute engine, aims to eliminate bottlenecks in innovation, allowing researchers to focus on scientific discovery rather than IT challenges.

Peptone Ltd is a London-based company founded in 2016 that specializes in artificial intelligence solutions aimed at solving protein developability challenges within the biotechnology, biopharmaceutical, and life sciences sectors. The company offers a range of services, including antibody design and optimization, an extensive protein database, automated thermos-stability engineering, and the deployment of hybrid AI solutions. Its proprietary platform, CassandraAI, focuses on silico protein engineering, allowing for the efficient handling of complex tasks related to anomaly detection and failure risk assessment in protein development. By streamlining these processes, Peptone enables users to identify optimal pathways for therapeutic discovery, facilitating the generation of lab-quality molecules more swiftly and cost-effectively than traditional methods in the pharmaceutical industry.

Aspen RxHealth is a Tampa, Florida-based company that provides an online platform designed to connect licensed pharmacists with patients requiring enhanced medication services. Through its app-based technology, Aspen RxHealth facilitates direct patient care by matching pharmacists with patients based on various social and clinical criteria, including language and medication regimens. The platform enables health plans and providers to efficiently link their patients to a community of pharmacists who can offer specialized clinical services, ranging from comprehensive medication reviews to targeted interventions. By optimizing communication and simplifying processes, Aspen RxHealth aims to improve patient outcomes and enhance the delivery of pharmaceutical care.

H1 provides a global healthcare platform that connects life sciences companies, hospitals, academic medical centers, and health systems with providers, enables access to clinical research, helps locate industry experts, and supports benchmarking of organizations. As a trusted source of information on healthcare professionals and institutions, the platform combines real-time data and clinical findings to illuminate the broader healthcare ecosystem. The company, founded in 2017 and based in New York, also offers a healthcare data analytics capability that delivers real-time, end-to-end insights across the data landscape to support therapeutic development—from fundraising and product development to product launch.

Koneksa Health Inc. is a healthcare data analytics company that specializes in designing and developing software solutions for pharmaceutical and biotech firms. The company’s flagship product, Koneksa Compare, facilitates the collection, monitoring, and analysis of patient-generated data to support clinical studies and regulatory claims. By integrating emerging technologies such as bio-sensors, activity trackers, and mobile-based questionnaires, Koneksa enhances the accuracy and breadth of data that researchers can analyze, thereby minimizing subjective biases in clinical endpoints. Additionally, the platform provides a dashboard that offers electronic clinical outcome assessments and reminders for study participants. Established in 2013 and headquartered in New York, Koneksa also maintains a presence in London, United Kingdom, and is recognized for its contributions to improving the efficiency of drug development through innovative data analysis.

H1 provides a global healthcare platform that connects life sciences companies, hospitals, academic medical centers, and health systems with providers, enables access to clinical research, helps locate industry experts, and supports benchmarking of organizations. As a trusted source of information on healthcare professionals and institutions, the platform combines real-time data and clinical findings to illuminate the broader healthcare ecosystem. The company, founded in 2017 and based in New York, also offers a healthcare data analytics capability that delivers real-time, end-to-end insights across the data landscape to support therapeutic development—from fundraising and product development to product launch.

Vineti, Inc. is a technology company focused on advancing the development and delivery of personalized therapies, particularly in the realm of cell and gene treatments for serious conditions like cancer. Founded in 2016 and headquartered in San Francisco, California, Vineti offers a cloud-based platform known as the Personalized Therapy Management (PTM) platform. This platform integrates various aspects of the therapeutic supply chain, including operations, manufacturing, quality assurance, and regulatory compliance, to streamline and automate processes. It addresses critical challenges faced by patients, healthcare providers, pharmaceutical companies, and regulatory bodies in the commercialization of personalized medicine. By enhancing supply chain orchestration and ensuring compliance with regulatory standards, Vineti aims to expand patient access to innovative therapies. The company also maintains regional offices in Bethesda, Maryland, and Yerevan, Armenia.

RxVantage, Inc. is a healthcare technology company based in El Segundo, California, founded in 2007. It offers a web-based digital platform that connects healthcare providers with educational resources and experts from life science companies. The platform streamlines interactions between medical representatives and physicians' offices, enhancing patient outcomes and improving the efficiency of communication. By allowing practices to manage their interactions with pharmaceutical reps, RxVantage alleviates the burden of scheduling and coordination, thereby enabling healthcare staff to focus more on patient care. The platform includes features such as a dedicated scheduling calendar, a communication hub for efficient interactions, and resources for patient assistance and drug coupons. With over 11,000 representatives from 400 companies utilizing its services, RxVantage has facilitated more than 120,000 appointments with high-prescribing physicians, generating significant value for the pharmaceutical industry. The company aims to expand its reach and continue increasing the productivity of medical representatives, ultimately enhancing the educational resources available to healthcare providers.

Founded in 2014, Animantis develops a cloud-based artificial intelligence platform for drug discovery. Its solution characterizes cellular function to guide advancements in medicine.

Xealth is a digital health technology company that provides a platform enabling clinicians to integrate, prescribe, and monitor digital health tools within electronic health record workflows. The Xealth platform helps care teams select appropriate digital health tools and programs, deliver orders to patients via email or patient portal, and track patient engagement and utilization, at both individual and system levels. The platform supports patient education and connects with online third-party apps and programs, device monitoring, and non-clinical services such as ride-sharing, food delivery, and e-commerce recommendations. Founded in 2016 and based in Seattle, Xealth focuses on scaling healthcare workflows by automating the prescription and monitoring of digital health tools to improve engagement and outcomes.

Cala Health is a bioelectronic medicine company that develops wearable neuromodulation therapies for chronic diseases. Its primary product, Cala Trio therapy, is a non-invasive prescription treatment for essential tremor.

SchoolCare is a digital health platform that provides free health technology to K-12 public schools, enabling school nurses to deliver effective care and enhance student safety. The company aims to create a unified health record for every family by leveraging pediatric health data within the extensive K-12 school system, which serves as a vital public health infrastructure. SchoolCare's platform captures essential student medical information, including charts, medications, and immunizations, while facilitating communication between schools, families, and healthcare providers. By addressing gaps in traditional care coordination, SchoolCare ensures that crucial care instructions reach school nurses, thereby reducing the risk of inconsistent post-discharge care. Through its innovative approach, SchoolCare seeks to improve health outcomes for children and streamline public school health programs across the United States.

Science 37 specializes in decentralized clinical trials, offering a technology-driven approach that enables patients to participate from their homes. The company's platform connects researchers with patients via telemedicine investigators and mobile nurses, accelerating trial enrollment and retention while reaching a more diverse patient population.

Aktana is a technology company that builds an AI‑driven decision support platform for life science organizations. Its software integrates with existing CRM workflows to analyze market data, channel activity, and healthcare professional preferences in real time. The platform delivers actionable insights and suggested actions to sales and marketing teams, enabling them to optimize engagement with prescribing physicians and refine multichannel campaigns. Since its founding in 2008, Aktana has served more than 100 brands, including a majority of the world’s top pharmaceutical companies, and operates from offices in San Francisco, New York, London, Barcelona, Tokyo, Osaka, and Shanghai.

Founded in 2017, Mekonos specializes in the development of gene and cell therapies. The company designs integrated system-on-a-chip technology to create predictive models for discovery and development, and operates a proprietary cell-engineering platform based on scalable silicon technology.

Pear Therapeutics, Inc. is a Boston-based commercial-stage healthcare company specializing in software-based digital therapeutics, also known as Prescription Digital Therapeutics (PDTs). Founded in 2013, the company develops clinically validated software solutions designed to treat a range of behavioral health disorders, including addiction, anxiety, depression, and chronic insomnia. Its suite of products includes mobile digital therapies that reward patients for engagement, and specific tools like reSET and reSET-O, aimed at treating substance use disorders. The company also offers Somryst, which provides neurobehavioral interventions for insomnia, and operates PearConnect, a patient services center that connects patients with advocates and resources, ensuring support throughout their treatment journey. Pear Therapeutics aims to enhance treatment outcomes by integrating digital therapies with pharmaceuticals and providing comprehensive support for patients, clinicians, and payors.

Science 37 specializes in decentralized clinical trials, offering a technology-driven approach that enables patients to participate from their homes. The company's platform connects researchers with patients via telemedicine investigators and mobile nurses, accelerating trial enrollment and retention while reaching a more diverse patient population.

Science 37 specializes in decentralized clinical trials, offering a technology-driven approach that enables patients to participate from their homes. The company's platform connects researchers with patients via telemedicine investigators and mobile nurses, accelerating trial enrollment and retention while reaching a more diverse patient population.

COTA, Inc. is a Boston-based company that specializes in developing a platform designed to provide data and insights related to cancer patients, aimed at guiding treatment decisions. Founded in 2011 by a team of doctors, engineers, and data scientists, COTA utilizes proprietary technology and advanced analytics to transform fragmented electronic health record (EHR) data into cohesive, research-grade information. This platform supports oncology practices and cancer centers by identifying variations in care, thus enabling the design of effective treatment programs and payment models. COTA's solutions serve a diverse range of stakeholders, including healthcare providers, payers, life sciences companies, and the FDA, ultimately striving to enhance patient outcomes and reduce healthcare costs associated with cancer care.

Cala Health is a bioelectronic medicine company that develops wearable neuromodulation therapies for chronic diseases. Its primary product, Cala Trio therapy, is a non-invasive prescription treatment for essential tremor.

Science 37 specializes in decentralized clinical trials, offering a technology-driven approach that enables patients to participate from their homes. The company's platform connects researchers with patients via telemedicine investigators and mobile nurses, accelerating trial enrollment and retention while reaching a more diverse patient population.

Omada Health is a digital healthcare company that offers personalized programs to manage chronic conditions such as prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health. It combines professional coaching, connected devices, real-time data, and personalized feedback to deliver clinically meaningful results.

Founded in 1999, SomaLogic specializes in the discovery, development, and commercialization of life science research tools and clinical diagnostic products centered around its proprietary SOMAmer/SOMAscan technology. This platform enables protein measurement at scale, facilitating biomarker discovery for various diseases, drug development, and clinical diagnostics.